Showing results (721-730 of 787) with videos related to

Sort By:
Pageof 79
British Journal of Cancer|October 16, 2008
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinomaF Rückert, M Hennig, C D Petraki, et al.
The FEBS Journal|May 18, 2006
Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14Loyse M Felber, Christoph Kündig, Carla A Borgoño, et al.
Experimental and Molecular Pathology|July 19, 2017
HtrA3 stromal expression is correlated with tumor budding in stage II colorectal cancerCatherine L Forse, Mahdi Rahimi, Eleftherios P Diamandis, et al.
Plos One|November 27, 2013
Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1Eric E Niederkofler, David A Phillips, Bryan Krastins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 10, 2015
Effectiveness of the risk of malignancy index and the risk of ovarian malignancy algorithm in a cohort of women with ovarian cancer: does histotype and stage matter?Genevieve K Lennox, Lua R Eiriksson, Clare J Reade, et al.
Journal of Proteome Research|January 8, 2014
Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoformsEduardo Martínez-Morillo, Henrietta M Nielsen, Ihor Batruch, et al.
International Journal of Cancer|May 4, 2023
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancerTimo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, et al.
International Journal of Cancer|July 8, 2003
Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinomaCarla A Borgoño, Stefano Fracchioli, George M Yousef, et al.
Clinical Chemistry and Laboratory Medicine|April 1, 2017
Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)Eleftherios P Diamandis, Frank Z Stanczyk, Sarah Wheeler, et al.
F1000Research|September 8, 2018
Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progressionIlijana Begcevic, Magda Tsolaki, Davor Brinc, et al.
Pageof 79